Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of immunoglobulins (antibodies) and lactoferrin, both naturally occurring proteins with roles in immune defense. Immunoglobulins are key components of the adaptive immune system, neutralizing pathogens and facilitating their clearance. Lactoferrin is an iron-binding glycoprotein found in milk and other secretions, known for its antimicrobial, antiviral, anti-inflammatory, and immunomodulatory properties. The combination aims to enhance host immunity by leveraging the pathogen-neutralizing effects of antibodies alongside lactoferrin’s ability to sequester iron (limiting microbial growth), modulate inflammatory responses, block viral entry into cells (including via ACE2 or HSPG receptors), and support gut health. This combination may be used as a dietary supplement or adjunctive therapy for infectious diseases or immune support[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on immunoglobulins + lactoferrin.